Efficacy of Ruxolitinib for Myelofibrosis

Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1517/14656566.2014.923404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy